SANGEETA BORKAR: Open Payments
NPI 1386380640 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 17 payments from 8 companies in 2025. Trend: 2023 $1,016 · 2024 $238 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $200 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| PFIZER INC. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Novo Nordisk Inc | 1 | $30 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: REPATHA, RECORLEV, OTEZLA, ZAVZPRET, AIRSUPRA, Ozempic, CRYSVITA, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
